Re: Rustom P. Manecksha, Ivor M. Cullen, Sarfraz Ahmad, et al. Prospective randomised controlled trial comparing trigone-sparing versus trigone-including intradetrusor injection of abobotulinumtoxina for refractory idiopathic detrusor overactivity. Eur Urol 2012;61:928-35.
Pascal
P
Mouracade
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*
D019274:Botulinum Toxins, Type A; C542869:abobotulinumtoxinA